LakeShore Biopharma Co., Ltd s (LSBPW) SEC News Jan. 13, 2026, 21:02 UTC 6 0 comments New Form SC 13E3/A - LakeShore Biopharma Co., Ltd. Filed: 2026-01-13 AccNo: 0001213900-26-003903 Size: 1 MB Comment Full text
Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 20:58 UTC 5 1 comments 📋 Chopas James George (Officer) plans to sell 873 shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $19K) Filed: Jan 13, 2026 | ID: 000284 Comment Full text
Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 20:55 UTC 5 1 comments 📋 Watson David O. (Officer) plans to sell 6K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $128K) Filed: Jan 13, 2026 | ID: 000283 Comment Full text
Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 20:53 UTC 5 1 comments 📋 DeLong Mark Jeffrey (Officer) plans to sell 2K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $39K) Filed: Jan 13, 2026 | ID: 000282 Comment Full text
Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 20:48 UTC 5 1 comments 📋 Deschatelets Pascal (Officer) plans to sell 2K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $51K) Filed: Jan 13, 2026 | ID: 000281 Comment Full text
Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 20:45 UTC 5 1 comments 📋 Francois Cedric (Officer) plans to sell 10K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $226K) Filed: Jan 13, 2026 | ID: 000280 Comment Full text
Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 20:40 UTC 4 1 comments 📋 Sullivan Timothy Eugene (Officer) plans to sell 4K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $86K) Filed: Jan 13, 2026 | ID: 000278 Comment Full text
EDAP TMS S.A. (EDAP) SEC News Jan. 13, 2026, 20:32 UTC 4 0 comments New Form 3 - EDAP TMS SA Filed: 2026-01-13 AccNo: 0001829126-26-000279 Size: 16 KB Comment Full text
EDAP TMS S.A. (EDAP) SEC News Jan. 13, 2026, 20:28 UTC 4 0 comments New Form 3 - EDAP TMS SA Filed: 2026-01-13 AccNo: 0001829126-26-000278 Size: 21 KB Comment Full text
Clene Inc. (CLNNW) SEC News Jan. 13, 2026, 19:48 UTC 3 1 comments Director MATLIN DAVID J 🟢 acquired 33.3K shares (2 derivative) of Clene Inc. (CLNN) at $6.50 Transaction Date: Jan 13, 2026 | Filing ID: 001170 Comment Full text